Reviews on covid drug development
32226821 2020. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
32292689 ä. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
32318328 ä. D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19
32152082 2020. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus
32232214 2020. Potential Treatments for COVID-19; a Narrative Literature Review
32134278 2020. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)
32375268 2020. Coronavirus Pandemic-Therapy and Vaccines
31996494 2020. Drug treatment options for the 2019-new coronavirus (2019-nCoV)
32334062 ä. Current status of potential therapeutic candidates for the COVID-19 crisis
32347359 ä. Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19
32194980 2020. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
32149769 ä. Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
32353634 2020. COVID-19: Immunology and treatment options
32280433 ä. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
32337328 2020. Coronaviruses: A patent dataset report for research and development (R&D) analysis
32309622 ä. Emerging Therapeutic Strategies for COVID-19 patients
32336723 2020. Treatment of SARS-CoV-2: How far have we reached?
32147628 2020. Discovering drugs to treat coronavirus disease 2019 (COVID-19)
32198066 ä. Advance of promising targets and agents against COVID-19 in China
32320852 ä. Deja vu: Stimulating open drug discovery for SARS-CoV-2
32304645 ä. Boosting the arsenal against COVID-19 through computational drug repurposing
32343658 2020. Medication for COVID-19-an Overview of Approaches Currently Under Study
32363880 2020. Medical treatment options for COVID-19
32372695 2020. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
32250170 2020. Will plant-made biopharmaceuticals play a role in the fight against COVID-19?
32317408 2020. Perspectives for repurposing drugs for the coronavirus disease 2019
32317405 2020. Tracking the impact of interventions against COVID-19 in absence of extensive testing
32201449 2020. Drug targets for corona virus: A systematic review
32320825 ä. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
32335561 2020. Update on treatment of COVID-19: ongoing studies between promising and disappointing results
32311668 ä. SARS-Cov-2 infection: response of human immune system and possible implications for the rapid test and treatment
32278811 ä. Drug repositioning is an alternative for the treatment of coronavirus COVID-19
32272396 ä. The Possible of Immunotherapy for COVID-19: a Systematic Review
32251732 ä. Perspectives: potential therapeutic options for SARS-CoV-2 patients based on feline infectious peritonitis strategies: central nervous system invasion and drug coverage
32305589 ä. Combating Devastating COVID -19 by Drug Repurposing
32325767 2020. COVID-19 Drug Discovery Using Intensive Approaches
32234466 ä. Coronavirus disease 2019 (COVID-19): current status and future perspectives
32255648 ä. A Community Letter Regarding Sharing Biomolecular Simulation Data for COVID-19
32315171 ä. Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
32243270 2020. Potential therapeutic agents against COVID-19: What we know so far
32314081 ä. Pharmacologic Therapy for COVID-19 Infection
32326602 2020. Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19
32307245 ä. Treatment options for COVID-19: The reality and challenges
32251618 2020. Current Drugs with Potential for Treatment of COVID-19: A Literature Review
32361836 ä. CNS penetration of potential anti-COVID-19 drugs
32374264 2020. Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point
32321634 2020. Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
32186952 2020. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
32341599 2020. Is Immuno-modulation the Key to COVID-19 Pandemic?
32293807 2020. Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID?19: initial assessment
32356252 ä. COVID-19: Therapeutics and Their Toxicities
32052466 2020. Potential interventions for novel coronavirus in China: A systematic review
32346490 ä. Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
32035018 2020. Reducing mortality from 2019-nCoV: host-directed therapies should be an option
32317113 2020. COVID-19 therapeutic options for patients with kidney disease
32220278 2020. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
32305088 2020. Flooded by the torrent: the COVID-19 drug pipeline
32199468 ä. Use of antiviral drugs to reduce COVID-19 transmission
32325035 ä. Plea for multitargeted interventions for severe COVID-19
32113509 2020. COVID-19: combining antiviral and anti-inflammatory treatments
32368737 2020. Preventing COVID-19-induced pneumonia with anticytokine therapy
32278693 2020. In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
32198163 2020. Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection
32292909 2020. Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies
32370766 2020. Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
32231348 2020. Emerging prophylaxis strategies against COVID-19
32296135 ä. COVID-19: risk for cytokine targeting in chronic inflammatory diseases?
32284951 2020. Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
32369479 2020. Antibody-based therapies for COVID-19: Can Europe move faster?
32360583 ä. Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis
32343686 2020. Pandemic responses: Planning to neutralize SARS-CoV-2 and prepare for future outbreaks
32360480 ä. Candidate drugs against SARS-CoV-2 and COVID-19
32290348 2020. COVID-19: A Brief Overview of the Discovery Clinical Trial
32360585 ä. Current targeted therapeutics against COVID-19: based on first-line experience in china
32098302 2020. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
32256547 2020. Clinical trials on drug repositioning for COVID-19 treatment
32333199 ä. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19
32313660 2020. A short review on antibody therapy for COVID-19
C7110269 ä. COVID-19 Outbreak: an Update on Therapeutic Options
32124179 ä. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need
32334088 ä. SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
32278175 ä. COVID-19: A promising cure for the global panic
32293834 2020. Antiviral treatment of COVID-19
32371057 ä. Potential applications of plant biotechnology against SARS-CoV-2
32291112 ä. Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
32287799 2020. Drug trials under way
32187463 ä. Covid-19 ? The Search for Effective Therapy
32274985 2020. Novel Coronavirus Disease (COVID-19): The Need for Immunoprevention at Industrial Scale
32354113 2020. On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges
32326343 2020. Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?
32213152 2020. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
| 32376392 ä. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions |
32217607 2020. Covid-19: what treatments are being investigated?
32304110 2020. Dosing will be a key success factor in repurposing antivirals for COVID-19
32356569 2020. Challenges in Drug Development Posed by the COVID-19 Pandemic: An Opportunity for Clinical Pharmacology
32368792 2020. Potential Therapeutic Targets and Promising Drugs for Combating SARS-CoV-2
| 32358833 2020. A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development IUPHAR Review 29 |
32329520 2020. Current pharmacological treatments for COVID-19: What s next?
32371479 2020. Cytokine Storm Drugs Move from CAR T to COVID-19
32303509 2020. Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19
32344310 2020. Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality
| 32324951 2020. Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics |
32366720 2020. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
32209549 2020. Covid-19: trials of four potential treatments to generate "robust data" of what works
32205349 2020. Updated Approaches against SARS-CoV-2
| 32376394 ä. Immunomodulatory therapy for the management of severe COVID-19 Beyond the anti-viral therapy: A comprehensive review |
| 32376397 ä. Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view |
32329159 2020. Thoughts on What Chemists Can Contribute to Fighting SARS-CoV-2 - A Short Note on Hand Sanitizers, Drug Candidates and Outreach
32277367 ä. Rheumatologists? perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
32345616 2020. Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19
32304395 2020. COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support
32203437 ä. Insights from nanomedicine into chloroquine efficacy against COVID-19
32360420 ä. Cytokine storm intervention in the early stages of COVID-19 pneumonia
32272550 2020. Antiviral Agents: Discovery to Resistance
32268515 2020. In Silico Discovery of Candidate Drugs against Covid-19
32357553 2020. Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19
32117569 2020. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China
32295237 2020. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs
32133962 2020. Effective Chemicals against Novel Coronavirus (COVID-19) in China
32373994 2020. Could host cell receptor alteration prevent SARS-CoV-2 viral entry? - Hype or hope
32362193 2020. Quadruple therapy for asymptomatic COVID-19 infection patients
32227357 ä. COVID?19 treatment by repurposing drugs until the vaccine is in sight
32377559 ä. COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus
32306822 2020. Peptide-like and small-molecule inhibitors against Covid-19
32317431 2020. Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future
32370727 2020. SARS-CoV-2 & Covid-19: Key-Roles of the Renin-Angiotensin System / Vitamin D Impacting Drug and Vaccine Developments
32281695 2020. Existing bitter medicines for fighting 2019-nCoV-associated infectious diseases
32379896 2020. Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs
32239514 ä. Comments on Zhang et al: Clinical trial analysis of 2019?nCoV therapy registered in China
32157732 ä. Harnessing the immune system via Fc?R function in immune therapy: a pathway to next?gen mAbs
32380023 ä. Immunomodulation in COVID-19
32289216 2020. Drug Evaluation during the Covid-19 Pandemic
32372435 2020. Drug repurposing in the era of COVID-19: a call for leadership and government investment
32273591 2020. The COVID-19 vaccine development landscape
| 32378459 2020. Application of nanomaterials in treatment, anti-infection and detection of coronaviruses |
| 32363750 2020. A Chemographic Audit of anti-Coronavirus Structure-Activity Information from Public Databases (ChEMBL) |
| 32353859 2020. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing |
32269311 2020. Coordinating the COVID-19 pipeline
32127666 2020. Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
32324177 2020. Some drugs for COVID-19
32208486 2020. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics
32297900 2020. Finding Effective Treatments for COVID-19: Scientific Integrity and Public Confidence in a Time of Crisis
32282022 2020. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review
32216577 2020. Artificial intelligence and machine learning to fight COVID-19
32219882 ä. Controversial treatments: An updated understanding of the coronavirus disease 2019
32297985 2020. Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID-19) Pneumonia in Shanghai, China
32108352 ä. Clinical trial analysis of 2019?nCoV therapy registered in China
32259313 2020. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
C7187737 ä. COVID-19 and the Rationale for Pharmacotherapy: A South African Perspective
32164080 2020. Potential antiviral therapeutics for 2019 Novel Coronavirus
32164081 2020. Pharmacotherapeutics for the new coronavirus pneumonia
32164077 2020. Pharmacotherapeutic about the new coronavirus pneumonia
C7197606 ä. Antibody therapies for the treatment of COVID-19
32302280 2020. Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department
32220178 2020. Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019
32376392 2020. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
32099652 2020. Frontiers in antiviral therapy and immunotherapy
32243785 2020. Embracing the Landscape of Therapeutics
C7117595 ä. Drug repurposing strategies for COVID-19
32377559 ä. COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus
32364041 2020. Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2
C7202831 ä. Testing COVID-19 therapies to prevent progression of mild disease
32201439 2020. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
32105468 2020. Structure-Based Stabilization of Non-native Protein?Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design
32081774 2020. Discovery and development of safe-in-man broad-spectrum antiviral agents
28664850 2017. (+)Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome
32382315 2020. Can graphene take part in the fight against COVID-19?
32313660 2020. A short review on antibody therapy for COVID-19
32317764 ä. Developing therapeutic monoclonal antibodies at pandemic pace
31432544 2020. Repurposing approved drugs on the pathway to novel therapies
32373787 2020. A new paradigm for drug development
32409074 2020. An overview of functional nanoparticles as novel emerging antiviral therapeutic agents
C7190528 ä. Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
